期刊文献+

迁延26年原发性骨髓纤维化转化为急性巨核细胞白血病一例分析及文献复习 被引量:3

Acute megakaryocytic leukemia transformed from idiopathic myelofibrosis after 26 years: a case report and review
原文传递
导出
摘要 目的探讨原发性骨髓纤维化转化为急性巨核细胞白血病患者临床表现、实验室检查特点及骨髓纤维化的预后因素。方法对病程迁延26年原发性骨髓纤维化转化为急性巨核细胞白血病老年患者1例临床资料进行分析,转变前后进行骨髓细胞形态学、细胞遗传学及JAK2V617F点突变检测;使用标准去甲氧柔红霉素+阿糖胞苷、高三尖杉酯碱+阿糖胞苷、米托蒽醌+阿糖胞苷等方案序贯治疗。结果转变前后检测患者JAK2V617F点突变均为阳性,染色体均为正常核型。先后予以标准去甲氧柔红霉素+阿糖胞苷、米托蒽醌+阿糖胞苷、高三尖杉酯碱+阿糖胞苷、吡柔比星+阿糖胞苷等方案序贯治疗达到完全缓解后,至今生存良好。结论染色体核型与骨髓纤维化的预后相关,核型正常的骨髓纤维化转变为M7经合理化疗后仍能达到完全缓解。 Objective To investigate the clinical data and laboratory features of acute megakaryocytic leukemia transformed from idiopathic myelofibrosis after 26 years in one case and the prognostic factors of myelofibrosis. Methods A case of acute megakaryocytic leukemia (M7) transformed from idiopathic myelofibrosis after 26 years was reported, and the clinical data was analyzed. Bone marrow cytology, cytogenetic and mutation detection in JAK2V617F were detected before and after transformation. Standard chemotherapeutic protocols including idarubicin plus cytarabine ( IDA), homoharringtonine and cytarabine ( HA), mitoxantrone and cytarabine ( MA), pirarubicin plus cytarabine (TA) sequential therapies were performed. Results JAK2V617F mutation and normal karyotype were found before and after the transformation. This patient was treated with standard chemotherapeutic protocols of IDA, HA, MA and TA sequential therapies until getting complete remission, and he lived well till now. Conclusions Chromosome karyotype is related to the prognosis of IMF. Acute megakaryocytic leukemia (M7) with the normal karyotype transformed from the IMF can achieve complete remission by rational consecutive chemotherapy.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2013年第10期1087-1089,共3页 Chinese Journal of Geriatrics
基金 国家自然基金项目资助(81170489)
关键词 原发性骨髓纤维化 白血病 原始巨细胞 急性 Primary myelofibrosis Leukemia, Megakaryoblastic, Acute
  • 相关文献

参考文献10

  • 1Jurisic V, Colovic N, Terzic T, et al. Transformation of primary myelofibrosis with 20q-in Philadelphia positive acute lymphoblastic leukemia: Case report and review of literature. Pathol Res Pract, 2012, 208.. 420-423.
  • 2Cerullo G, Korotkevych Y, Montalvao A, Starting point macrocytic anemia arrival idiopathic myelofibrosis. Euro J Internal Med, 22 : s19.
  • 3Oki Y, Kantarjian HM, Zhou X, et al. Adult acute megakaryoeytic leukemia: an analysis of 37 patients treated at MD Anderson Cancer Center. Blood,2006, 107:880-884.
  • 4Barosi G, Ambrosetti A, Centra A, et al. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia. Blood, 1998,91 : 3630-3636.
  • 5Caldwell JT, Edward H, Dombkowski AA, et al. Overexpression of GATA1 confers resistance to chemotherapy in acute megakaryocytic leukemia. Plos One, 2013, 8: 1-12.
  • 6Cervantes F, Dupriez B, Pereira A, et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood, 2009,113:2895 2901.
  • 7Toubai T, Tanaka J, Higa T, et al. Long-term follow-up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities. Am J Hematol,2005, 78:67- 70.
  • 8Wen HX, Li YJ, Malek SN, et al. New fusion transcripts identified in normal karyotype acute myeloid leukemia. Plos One, 2012, 7: 1-10.
  • 9Hirose Y, Masaki Y, Shimoyama K, et al. Granuloeytic sarcoma of megakaryoblastic differentiation in the lymph nodes terminating as acute megakaryoblastic leukemia in a case of chronic idiopathic myelofibrosis persisting for 16 years. Eur J Haematol, 2001,67 : 194-198.
  • 10Abdel-Wahab OI, Levine RL. Primary myelofibrosis., update on definition, pathogenesis, and treatment. AnnuRev Med, 2009, 60: 233-245.

同被引文献20

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部